Oxaliplatin
- Product NDC
- 63323-750
- 11-digit product format
- 633230750
- Labeler code
- 63323
- Product ID
- 63323-750_504bf43e-4c28-4375-a6f4-285b2357f7f7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxaliplatin
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA078811
- Marketing category
- ANDA
- Marketing start
- 2010-06-11
- Substance
- OXALIPLATIN
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oxaliplatin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXALIPLATIN | 5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 04ZR38536J |
| Rxcui | 1736776, 1736781 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-750-10 | Oxaliplatin | 1 in 1 BOX | INJECTION, SOLUTION, CONCENTRATE | 1 | | 15 |
| 63323-750-10 | Oxaliplatin | 10 mL in 1 VIAL | INJECTION, SOLUTION, CONCENTRATE | 10 | | 15 |
| 63323-750-20 | Oxaliplatin | 1 in 1 BOX | INJECTION, SOLUTION, CONCENTRATE | 1 | | 15 |
| 63323-750-20 | Oxaliplatin | 20 mL in 1 VIAL | INJECTION, SOLUTION, CONCENTRATE | 20 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| OXALIPLATIN | ACTIVE INGREDIENT | 04ZR38536J | OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC] | 10 | |
| OXALIPLATIN | ACTIVE MOIETY | 04ZR38536J | OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC] | 10 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC] | 10 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-750 | OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC
] | 14 | Current NDC, Legacy NDC, 4 package rows | 20211020_e12e2850-4980-48de-af58-15e559fb921f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-750-10 | 63323075010 | 1 VIAL in 1 BOX (63323-750-10) > 10 mL in 1 VIAL | 1 vial | 2010-06-11 | 0000-00-00 | No | No | Current |
| 63323-750-20 | 63323075020 | 1 VIAL in 1 BOX (63323-750-20) > 20 mL in 1 VIAL | 1 vial | 2010-06-11 | 0000-00-00 | No | No | Current |